Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-Δ12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells

D. K. Vanaja, M. E. Grossmann, Esteban Celis, C. Y.F. Young

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The biological modifier Δ12-prostaglandin J2 and related prostaglandins have been reported to have significant growth-inhibitory activity with induction of heat shock proteins (Hsps). Tumor-derived Hsps have been shown previously to elicit specific immunity to tumors from which they are isolated. In this study, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)-induced Hsp70 was purified from transgenic adenocarcinoma mouse prostate cells (TRAMP-C2). It was then tested for its ability to activate specific CTLs and induce protective immunity against prostate cancer in C57BL/6 mice. Treatment of cells with 8.0 μM 15d-PGJ2 for 24 h caused significant induction of Hsp70 expression. The yield of Hsp70 purified from 15d-PGJ2-treated cells was 4-5-fold higher when compared with untreated TRAMP-C2 cells. Vaccination of mice with Hsps isolated from TRAMP-C2 cells elicited tumor-specific CTLs and prevented the growth of TRAMP-C2 tumors. These results indicate that the induced heat shock proteins may have promising applications for antitumor, T-cell immunotherapy. In particular, these findings have important implications for the development of novel anticancer therapies aimed at promoting an immune response to prostate tumors.

Original languageEnglish (US)
Pages (from-to)4714-4718
Number of pages5
JournalCancer Research
Volume60
Issue number17
StatePublished - Sep 1 2000
Externally publishedYes

Fingerprint

HSP70 Heat-Shock Proteins
Transgenic Mice
Prostate
Immunity
Heat-Shock Proteins
Adenocarcinoma
Neoplasms
Growth
Inbred C57BL Mouse
Immunotherapy
Prostaglandins
Prostatic Neoplasms
Vaccination
15-deoxy-delta(12,14)-prostaglandin J2
T-Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-Δ12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. / Vanaja, D. K.; Grossmann, M. E.; Celis, Esteban; Young, C. Y.F.

In: Cancer Research, Vol. 60, No. 17, 01.09.2000, p. 4714-4718.

Research output: Contribution to journalArticle

@article{e35982d8d89c49afac9dbb54b4d6a2a7,
title = "Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-Δ12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells",
abstract = "The biological modifier Δ12-prostaglandin J2 and related prostaglandins have been reported to have significant growth-inhibitory activity with induction of heat shock proteins (Hsps). Tumor-derived Hsps have been shown previously to elicit specific immunity to tumors from which they are isolated. In this study, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)-induced Hsp70 was purified from transgenic adenocarcinoma mouse prostate cells (TRAMP-C2). It was then tested for its ability to activate specific CTLs and induce protective immunity against prostate cancer in C57BL/6 mice. Treatment of cells with 8.0 μM 15d-PGJ2 for 24 h caused significant induction of Hsp70 expression. The yield of Hsp70 purified from 15d-PGJ2-treated cells was 4-5-fold higher when compared with untreated TRAMP-C2 cells. Vaccination of mice with Hsps isolated from TRAMP-C2 cells elicited tumor-specific CTLs and prevented the growth of TRAMP-C2 tumors. These results indicate that the induced heat shock proteins may have promising applications for antitumor, T-cell immunotherapy. In particular, these findings have important implications for the development of novel anticancer therapies aimed at promoting an immune response to prostate tumors.",
author = "Vanaja, {D. K.} and Grossmann, {M. E.} and Esteban Celis and Young, {C. Y.F.}",
year = "2000",
month = "9",
day = "1",
language = "English (US)",
volume = "60",
pages = "4714--4718",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-Δ12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells

AU - Vanaja, D. K.

AU - Grossmann, M. E.

AU - Celis, Esteban

AU - Young, C. Y.F.

PY - 2000/9/1

Y1 - 2000/9/1

N2 - The biological modifier Δ12-prostaglandin J2 and related prostaglandins have been reported to have significant growth-inhibitory activity with induction of heat shock proteins (Hsps). Tumor-derived Hsps have been shown previously to elicit specific immunity to tumors from which they are isolated. In this study, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)-induced Hsp70 was purified from transgenic adenocarcinoma mouse prostate cells (TRAMP-C2). It was then tested for its ability to activate specific CTLs and induce protective immunity against prostate cancer in C57BL/6 mice. Treatment of cells with 8.0 μM 15d-PGJ2 for 24 h caused significant induction of Hsp70 expression. The yield of Hsp70 purified from 15d-PGJ2-treated cells was 4-5-fold higher when compared with untreated TRAMP-C2 cells. Vaccination of mice with Hsps isolated from TRAMP-C2 cells elicited tumor-specific CTLs and prevented the growth of TRAMP-C2 tumors. These results indicate that the induced heat shock proteins may have promising applications for antitumor, T-cell immunotherapy. In particular, these findings have important implications for the development of novel anticancer therapies aimed at promoting an immune response to prostate tumors.

AB - The biological modifier Δ12-prostaglandin J2 and related prostaglandins have been reported to have significant growth-inhibitory activity with induction of heat shock proteins (Hsps). Tumor-derived Hsps have been shown previously to elicit specific immunity to tumors from which they are isolated. In this study, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)-induced Hsp70 was purified from transgenic adenocarcinoma mouse prostate cells (TRAMP-C2). It was then tested for its ability to activate specific CTLs and induce protective immunity against prostate cancer in C57BL/6 mice. Treatment of cells with 8.0 μM 15d-PGJ2 for 24 h caused significant induction of Hsp70 expression. The yield of Hsp70 purified from 15d-PGJ2-treated cells was 4-5-fold higher when compared with untreated TRAMP-C2 cells. Vaccination of mice with Hsps isolated from TRAMP-C2 cells elicited tumor-specific CTLs and prevented the growth of TRAMP-C2 tumors. These results indicate that the induced heat shock proteins may have promising applications for antitumor, T-cell immunotherapy. In particular, these findings have important implications for the development of novel anticancer therapies aimed at promoting an immune response to prostate tumors.

UR - http://www.scopus.com/inward/record.url?scp=0034282811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034282811&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 4714

EP - 4718

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 17

ER -